Manhattan Hematology Oncology MHO Associates /ID# 223193 — New York, New York

Manhattan Hematology Oncology MHO Associates /ID# 223193 is a clinical research site located in New York, New York, United States 10016-6028.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Manhattan Hematology Oncology MHO Associates /ID# 223193 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Myelofibrosis (MF).

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Manhattan Hematology Oncology MHO Associates /ID# 223193?

Manhattan Hematology Oncology MHO Associates /ID# 223193 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Manhattan Hematology Oncology MHO Associates /ID# 223193 conducted?

Manhattan Hematology Oncology MHO Associates /ID# 223193 has 1 clinical trials on record, with 1 currently active. Their work covers Myelofibrosis (MF).

Is Manhattan Hematology Oncology MHO Associates /ID# 223193 accredited by Crixeo Health?

Manhattan Hematology Oncology MHO Associates /ID# 223193 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Manhattan Hematology Oncology MHO Associates /ID# 223193?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.